The government plans to examine current drug pricing controls to make medicines more affordable, while undertaking a "reengineering" of the NPPA price regulator to provide greater transparency with respect to industry claims Of the arbitrary implementation of the policy. It established a panel of joint Secretaries of the Department of Pharmaceuticals (DoP), the Ministry of Health and Family Welfare, the Secretary of the NPPA and the India Comptroller General for Drugs (DGCI) , Among others, to recommend measures to make medicines more affordable.